Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1189107-28-5

Post Buying Request

1189107-28-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1189107-28-5 Usage

Derivative of

6-chloro-4-hydroxy-8-methoxyquinoline-3-carboxylic acid

Type

Quinoline carboxylic acid derivative

Properties

Antibacterial and antifungal

Uses

Synthesis of pharmaceutical compounds, production of drugs for bacterial and fungal infections

Potential applications

Agrochemicals, pharmaceuticals, research

Check Digit Verification of cas no

The CAS Registry Mumber 1189107-28-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,8,9,1,0 and 7 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1189107-28:
(9*1)+(8*1)+(7*8)+(6*9)+(5*1)+(4*0)+(3*7)+(2*2)+(1*8)=165
165 % 10 = 5
So 1189107-28-5 is a valid CAS Registry Number.

1189107-28-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 6-chloro-8-methoxy-4-oxo-1H-quinoline-3-carboxylate

1.2 Other means of identification

Product number -
Other names 6-Chloro-4-hydroxy-8-methoxyquinoline-3-carboxylic acid ethyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1189107-28-5 SDS

1189107-28-5Downstream Products

1189107-28-5Relevant articles and documents

TRICYCLIC COMPOUNDS AS MODULATORS OF TNF-α SYNTHESIS AND AS PDE4 INHIBITORS

-

Page/Page column 42, (2009/09/05)

The present invention relates to chemical compounds of Formula (I) are as herein defined, pharmaceutical compositions, and methods of use in the treatment of conditions or disorders mediated by TNF-alpha or by PDE4, including but not limited to rheumatoid arthritis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1189107-28-5